Related Experiment Video
Updated: Sep 16, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
[Study on the correlation between MASP-2 and diseases]
Yu Cao1, Yan Zhou2, Tianjun Jia3
1Key Laboratory of Clinical Laboratory Diagnostics, Hebei North University, Zhangjiakou 075000, China.
Abstract:
Mannose-binding lectin-associated serine protease 2(MASP-2) is a member of serine protease family and plays a crucial role in activating the complement lectin pathway. When mannose residues on the surface of a pathogen are recognized by mannose-binding lectins (MBL) or fibrinogen collagen (FCN), MASP-2 is activated. This activation then triggers the cleavage of C4 and C2 to form C3 convertase, thereby initiating the lectin pathway of the complement system. Numerous studies have demonstrated that MASP-2 gene polymorphisms and serum levels are closely related with various diseases, including tumors, infectious diseases, autoimmune diseases and so on. In this review, we summarize the relationships between MASP-2 and tumors, infectious diseases, autoimmune diseases. We aim to provide a theoretical basis for the early diagnosis, prognosis evaluation and clinical treatment of various diseases.
Insights
Mannose-binding lectin-associated serine protease 2 (MASP-2) is vital for the complement lectin pathway. MASP-2 gene variations and levels link to diseases like tumors and infections, aiding diagnosis and treatment.
Area of Science:
- Immunology
- Biochemistry
- Molecular Biology
Background:
- Mannose-binding lectin-associated serine protease 2 (MASP-2) is a key enzyme in the lectin pathway of the complement system.
- MASP-2 activation is triggered by mannose-binding lectins (MBL) or fibrinogen collagen (FCN) recognizing pathogen surfaces.
- This activation leads to the formation of C3 convertase, initiating complement cascade.
Purpose of the Study:
- To review the association between MASP-2 and various diseases.
- To explore the role of MASP-2 gene polymorphisms and serum levels in disease pathogenesis.
- To provide a theoretical basis for MASP-2 in disease diagnosis, prognosis, and treatment.
Main Methods:
- Literature review of studies on MASP-2 and diseases.
- Analysis of the role of MASP-2 in the complement lectin pathway.
- Synthesis of information on MASP-2 gene polymorphisms and serum levels in relation to diseases.
Main Results:
- MASP-2 is implicated in the activation of the complement lectin pathway.
- MASP-2 gene polymorphisms and serum levels are linked to tumors, infectious diseases, and autoimmune diseases.
- These findings highlight MASP-2's potential as a biomarker and therapeutic target.
Conclusions:
- MASP-2 plays a significant role in the immune response via the complement lectin pathway.
- The relationship between MASP-2 and various diseases warrants further investigation.
- MASP-2 holds promise for improving early diagnosis, prognosis, and clinical treatment strategies.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Abnormal Proliferation
Master Transcription Regulators

